World: U.S. nears deal to fund Moderna’s H5N1 vaccine trial, APHIS reports H5N1 in mammals, wild birds

게시됨 2024년 5월 31일

Tridge 요약

The U.S. government is nearing funding a late-stage trial for Moderna's mRNA H5N1 vaccine, with potential support from BARDA, while the U.S., Canada, and Europe are negotiating with CSL Seqirus and GSK for H5N1 vaccines for at-risk workers. New H5N1 detections have been reported in various states, affecting mammals and birds. China has lifted bans on imports from five Australian beef facilities and will allow Russian beef imports. Agri Stats faces a DOJ lawsuit for alleged price-fixing among meat companies. The global beef, pork, and dairy markets are experiencing mixed trends, with trade agreements impacting U.S. exports. Dairy market updates show varying trends in product prices and production levels, with notable increases in organic milk ads and slight declines in conventional milk sales.

면책 조항: 위의 요약은 정보 제공 목적으로 Tridge 자체 학습 AI 모델에 의해 생성되었습니다.

원본 콘텐츠

The U.S. government is nearing an agreement to fund a late-stage trial of Moderna’s mRNA H5N1 vaccine, the Financial Times reported, as the outbreak spreads. Federal funding from the Biomedical Advanced Research and Development Authority (BARDA) could come as soon as next month and would include a promise to procure doses if late-stage trials are successful, the report said, citing people close to the discussions. As we previously reported, the U.S., Canada and Europe have been in active talks with CSL Seqirus and GSK to acquire or manufacture H5N1 vaccines, which could be used to protect at-risk poultry and dairy workers, veterinarians and lab technicians. The U.S. government is also in “active conversations” with mRNA vaccine makers Pfizer and Moderna on a potential H5N1 vaccine for humans. USDA’s Animal and Plant Health Inspection Service (APHIS) reported 15 new H5N1 virus detections in mammals across six states, with sample dates from mid-April to mid-May. This includes ...

출처: The Cattle Site